【摘 要】
：
Objective: Effective adjuvant therapeutic strategies are urgently needed to overcome MAPK inhibitor (MAPKi) resistance, which is one of the most common forms of resistance that has emerged in many types of cancers. Here, we aimed to systematically identif
【机 构】
：
Department of Cell Biology,Basic Medical College,Army Medical University(Third Military Medical Univ
论文部分内容阅读
Objective: Effective adjuvant therapeutic strategies are urgently needed to overcome MAPK inhibitor (MAPKi) resistance, which is one of the most common forms of resistance that has emerged in many types of cancers. Here, we aimed to systematically identify the genetic interactions underlying MAPKi resistance, and to further investigate the mechanisms that produce the genetic interactions that generate synergistic MAPKi resistance.Methods: We conducted a comprehensive pair-wise sgRNA-based high-throughput screening assay to identify synergistic interactions that sensitized cancer cells to MAPKi, and validated 3 genetic combinations through competitive growth, cell viability, and spheroid formation assays. We next conducted Kaplan-Meier survival analysis based on The Cancer Genome Atlas database and conducted immunohistochemistry to determine the clinical relevance of these synergistic combinations. We also investigated the MAPKi resistance mechanisms of these validated synergistic combinations by using co-immunoprecipitation, Western blot, qRT-PCR, and immunofluorescence assays. Results: We constructed a systematic interaction network of MAPKi resistance and identified 3 novel synergistic combinations that effectively targeted MAPKi resistance (ITGB3 + IGF1R, ITGB3 + JNK, and HDGF + LGR5). We next analyzed their clinical relevance and the mechanisms by which they sensitized cancer cells to MAPKi exposure. Specifically, we discovered a novel protein complex, HDGF-LGR5, that adaptively responded to MAPKi to enhance cancer cell stemness, which was up- or downregulated by the inhibitors of ITGB3 + JNK or ITGB3 + IGF1R. Conclusions: Pair-wise sgRNA library screening provided systematic insights into elucidating MAPKi resistance in cancer cells. ITGB3- + IGF1R-targeting drugs (cilengitide + linsitinib) could be used as an effective therapy for suppressing the adaptive formation of the HDGF-LGR5 protein complex, which enhanced cancer stemness during MAPKi stress.
其他文献
Colorectal cancer (CRC) is the third most common and the second most fatal cancer. In recent years, more attention has been directed toward the role of gut microbiota in the initiation and development of CRC. Some bacterial species, such as Fusobacterium
Objective: There are many hereditary breast cancer patients in China, and multigene panel testing has been a new paradigm of genetic testing for these patients and their relatives. However, the magnitude of breast cancer risks related to multiple breast c
Objective: Protein convertase subtilisin/Kexin type 9 (PCSK9) has been found to be closely associated with the occurrence and development of numerous tumors. However, the precise role of PCSK9 and its relationship to the development of hepatocellular carc
Tumor tissues contain both tumor and non-tumor cells, which include infiltrated immune cells and stromal cells, collectively called the tumor microenvironment (TME). Single-cell RNA sequencing (scRNAseq) enables the examination of heterogeneity of tumor c
目的 探讨NF-КBp65蛋白和mRNA在鼻咽癌组织中的表达及其临床病理意义.方法 运用免疫组化和RT-PCR的方法检测NF-КBp65蛋白和mRNA在60例鼻咽癌和30例鼻咽炎组织中的表达,分析鼻咽癌组织NF-ΚBp65表达活性差异与鼻咽癌患者临床病理指标的相关性.结果 鼻咽癌组织中NF-КBp65蛋白和mRNA的表达明显高于鼻咽炎组织(P<0.05);鼻咽癌组织中NF-КBp65蛋白和mRNA的表达与肿瘤大小、淋巴结转移及临床分期有显著相关性(P<0.05);肿瘤体积越大、有淋巴结转移、临床分期越高的
Triple-negative breast cancer (TNBC) is a subtype of breast cancer characterized by its highly aggressive behavior, early recurrence, and poor outcomes, when compared with other subtypes. Due to the absence of the estrogen receptor, progesterone receptor,
Circular RNAs (circRNAs) are noncoding RNAs that form covalently closed loop structures. CircRNAs are dysregulated in cancer and play key roles in tumorigenesis, diagnosis, and tumor therapy. CircRNAs function as competing endogenous RNAs or microRNA spon
Objective: The dysregulation of ribosome biogenesis is associated with the progression of numerous tumors, including hepatocellular carcinoma (HCC). Small nucleolar RNAs (snoRNAs) regulate ribosome biogenesis by guiding the modification of ribosomal RNAs
目的 探讨静吸复合全麻和全凭静脉麻醉在卵巢癌患者中的使用.方法 选取2020年1月至2020年12月间上海市复旦大学附属华山医院收治50例卵巢癌患者,将患者根据不同麻醉方法分为对照组(静吸复合全麻)与观察组(全凭静脉麻醉)两组,每组25例.对比两组患者的CD3+、CD4+、一氧化氮(N0)和催乳素(PRL)影响.结果 观察组患者手术之后的CD3+和CD4+比对照组高,差异有统计学意义(P＜0.05).两组患者在诱导前的血清NO含量比较,差异无统计学意义(P＞0.05),两组切皮时和术中1h的血清NO含量都
个性化新抗原肿瘤疫苗逐渐崭露头角,在恶性黑色素瘤、肺癌、脑胶质瘤等肿瘤治疗领域取得了突破,展现了良好的应用前景.随着测序成本的降低、人工智能技术的不断突破和对肿瘤免疫理解的不断深入,对一个肿瘤患者进行全过程动态跟踪和捕捉其肿瘤相关体细胞突变的克隆多样性己成为可能,随之研发的新抗原肿瘤疫苗则成为肿瘤治疗的前沿热点,未来可期.本文从新抗原的筛选鉴定、新抗原相关的肿瘤疫苗及其临床应用现状、个性化新抗原肿瘤疫苗面临的挑战和未来发展趋势等五个方面,系统地总结了个性化新抗原肿瘤疫苗这一新兴的精准免疫治疗方法的研究脉络